Delivery Order SPE2DB20D3101-SPE2DB23FQWT0

Award Date 12/6/22
Potential Completion Date 12/7/22
Potential Value $6.2K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of 4,561,545,800 units of the medication Escitalopram 10 mg tablets. The $1,697.83 firm fixed-price contract has a period of performance through July 20, 2023 and was not designated as a set-aside. Amerisourcebergen, a subsidiary of the parent company Cencora, Inc., holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,558,315,503 units of the prescription medication escitalopram 10 mg tablets. The $4,681.90 firm-fixed-price delivery order has a completion date of September 2, 2022. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,748.20 firm fixed-price delivery order is for the supply of 4,563,865,533 units of the prescription medication escitalopram 20 mg tablet. The contract has an ultimate completion date of March 6, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,925.67 firm fixed-price delivery order is for the supply of 4,562,940 units of Escitalopram 10 mg tablets, a medication commonly used to treat mental health conditions. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which...
This federal contract award, valued at $3,996.25, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,563,667,024 units of escitalopram 10 mg tablets, a mental health medication. This is a firm fixed-price delivery order contract with a completion date of February 15, 2024. The contract was awarded on February 14, 2024, and has no set-aside designation, indicating it was awarded through full and open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The $1,239.69 firm fixed price delivery order is for the supply of 4,565,548,532 units of the pharmaceutical drug Escitalopram 10 mg tablets. The contract has an ultimate completion date of August 23, 2024 and was awarded on August 22, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA...
This federal contract award, valued at $1,390.50, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of escitalopram 10 mg tablets, a medication used to treat mental health conditions. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,635.38, is a delivery order for 4,562,280,822 units of the drug Escitalopram 10 mg tablets. The contract has an ultimate completion date of September 25, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,461.02 firm fixed-price contract is for the delivery of 4,562,019,744 units of the prescription drug Escitalopram 10 mg tablet. The contract has an ultimate completion date of September 1, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,323.72 firm-fixed-price delivery order is for the supply of 4,566,805,621 units of the medication Escitalopram 10 mg tablets. The contract has an ultimate completion date of December 31, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB23FQWT0
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,230.49 firm fixed-price delivery order is for the supply of 4,559,292,364 units of escitalopram 10 mg tablets. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with a ceiling value of $999,999,999.00. The IDC, which runs through November 2026, serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions globally. The contract award does not have a set-aside designation, indicating open competition. This delivery order is one of many that Amerisourcebergen has received from the DLA to supply essential medications and medical commodities to the Department of Defense and other federal agencies.

Generated 2/27/25, 12:35 PM